2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Pharmacogenomics & Personalized Medicine PHARMACOGEN PERS MED (此期刊被最新的JCR期刊SCIE收录) LetPub评分 5.8
51人评分
我要评分
声誉 7.1 影响力 4.7 速度 7.0 | |||||||||||||||||||||
期刊ISSN | 1178-7066 | 微信扫码收藏此期刊 | ||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 1.8 点击查看影响因子趋势图 | |||||||||||||||||||||
实时影响因子 | 截止2024年10月29日:1.389 | |||||||||||||||||||||
2023-2024自引率 | 0.00%点击查看自引率趋势图 | |||||||||||||||||||||
五年影响因子 | 1.9 | |||||||||||||||||||||
JCI期刊引文指标 | 0.56 | |||||||||||||||||||||
h-index | 暂无h-index数据 | |||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||
期刊官方网站 | https://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journal | |||||||||||||||||||||
期刊投稿网址 | https://www.dovepress.com/submit_step_1.php | |||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Pharmacogenomics & Personalized Medicine的语言要求,还能让Pharmacogenomics & Personalized Medicine编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Pharmacogenomics & Personalized Medicine编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(1篇) 。
提交文稿 | |||||||||||||||||||||
是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息 | 文章处理费:需要( USD3300; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:genomic profiling、genetics、pharmacology、drug metabolism 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||
通讯方式 | PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752 | |||||||||||||||||||||
出版商 | Dove Medical Press | |||||||||||||||||||||
涉及的研究方向 | Biochemistry, Genetics and Molecular Biology-Molecular Medicine | |||||||||||||||||||||
出版国家或地区 | New Zealand | |||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||
出版周期 | ||||||||||||||||||||||
出版年份 | 0 | |||||||||||||||||||||
年文章数 | 93点击查看年文章数趋势图 | |||||||||||||||||||||
Gold OA文章占比 | 98.46% | |||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 86.02% | |||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:3区
| |||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1178-7066%5BISSN%5D | |||||||||||||||||||||
平均审稿速度 | 网友分享经验: 16 Weeks | |||||||||||||||||||||
平均录用比例 | 网友分享经验: | |||||||||||||||||||||
版面费/APC文章处理费信息 | 文章处理费:需要( USD3300; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Pharmacogenomics & Personalized Medicine顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||
期刊常用信息链接 |
|
|
中国学者近期发表的论文 | |
1. | Resistance to PARP Inhibitors After First-Line Platinum-Based Chemotherapy in a Patient with Advanced Ovarian Cancer with a Pathogenic Somatic BRCA1 Mutation Author: Zhong, Lan; Yin, Rutie; Song, Liang Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 195-200. DOI: 10.2147/PGPM.S397827 PubMed DOI |
2. | Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma Author: Zheng, Chunlan; Peng, Yanan; Wang, Haizhou; Wang, Youwei; Liu, Lan; Zhao, Qiu Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 39-58. DOI: 10.2147/PGPM.S397892 PubMed DOI |
3. | NOTCH2, ATIC, MRI1, SLC6A13, ATP13A2 Genetic Variations are Associated with Ventricular Septal Defect in the Chinese Tibetan Population Through Whole-Exome Sequencing Author: Zhang, Xiaohui; Zhen, Da; Li, Xuemei; Yi, Faling; Zhang, Zhanhao; Yang, Wei; Li, Xuguang; Sheng, Yemeng; Liu, Xiaoli; Jin, Tianbo; He, Yongjun Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 389-400. DOI: 10.2147/PGPM.S404438 PubMed DOI |
4. | The Allelic Expression of RNA Editing Gene ADARB1 in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Author: Zeng, Jiajia; Han, Linyu; Wang, Teng; Huang, Linying; Zheng, Yanxiu; Zhang, Nasha; Li, Ziqiang; Yang, Ming Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 229-238. DOI: 10.2147/PGPM.S402115 PubMed DOI |
5. | LncRNA FOXD2-AS1 Increased Proliferation and Invasion of Lung Adenocarcinoma via Cell-Cycle Regulation Author: Yuan, Yuan; Yu, Peng; Shen, Huihua; Xing, Guozhu; Li, Wu Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 99-109. DOI: 10.2147/PGPM.S396866 PubMed DOI |
6. | Dysregulation of circRNA-0076906 and circRNA-0134944 is Correlated with Susceptibility to Osteoporosis and Osteoporotic Fracture in Postmenopausal Females from the Chinese Han Population Author: Yang, Weijie; Zhang, Wei; Li, Fengqian; Xu, Ning; Sun, Ping Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 183-194. DOI: 10.2147/PGPM.S394757 PubMed DOI |
7. | Massive Hepatocellular Carcinoma with Situs Inversus Totalis Achieved a Complete Response Following Camrelizumab Plus Apatinib and Combined with Two-Stage Hepatectomy: A Case Report Author: Wu, Yining; Ou, Shenjian; Liao, Xiwen; Han, Chuangye; Yang, Chengkun; Qin, Wei; Tan, Yufeng; Lao, Quan; Peng, Tao; Ye, Xinping Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 111-120. DOI: 10.2147/PGPM.S376596 PubMed DOI |
8. | Acute Myeloid Leukemia Secondary to Chronic Lymphocytic Leukemia After Prolonged Chlorambucil Therapy: A Case Report Author: Wu, Yan; Liu, Shan; Wang, Dongmei; Yao, Xinjie Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 401-405. DOI: 10.2147/PGPM.S407940 PubMed DOI |
9. | Apolipoprotein E Gene Polymorphism Effects on Lipid Metabolism and Risk of Cerebral Infarction in Northwest Han Chinese Population Author: Wang, Yaqi; Yang, Shuang; Zhang, Suya; Lu, Xiaoyu; Ma, Wenbing Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 303-312. DOI: 10.2147/PGPM.S404663 PubMed DOI |
10. | High Expression of DNTTIP1 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma Author: Wang, Xuegang; Li, Weiquan; Lou, Ning; Han, Weiwei; Hai, Bo; Xiao, Wen; Zhang, Xiaoping Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 1-14. DOI: 10.2147/PGPM.S382843 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室